Ensweet

Ensweet is a telemedicine company founded in 2020 that provides a remote solution for cardiac rehabilitation. The company was co-founded by Fabien Watrelot (CEO), who has a degree in connected health, along with Dr. Alexis Astruc and Dr. Guillaume Colin. The concept arose from the realization that digital technology could significantly improve access to effective cardiac rehabilitation care.

The firm targets patients with long-term cardiovascular conditions or those who have undergone cardiac surgery, aiming to address the low percentage of eligible patients—less than 30% in France—who access rehabilitation programs due to factors like facility saturation and travel difficulties. Ensweet's business model involves providing its CE-marked medical device and platform to healthcare facilities, which can then offer hybrid rehabilitation programs that combine in-center training with at-home follow-up. The services are now partially reimbursed by the French national health insurance (Assurance Maladie) under new telehealth regulations.

The Ensweet Cardio solution consists of a web interface for healthcare providers and a mobile application for patients. Clinicians can create customized exercise programs, monitor patient progress through data from a connected heart rate sensor, and communicate via integrated messaging and video conferencing. Patients follow their prescribed plans from home, which include physical activities, therapeutic education, and self-rehabilitation modules. The company also provides equipment, such as an exercise bike, to the patient's home. This approach is designed to increase patient compliance and allow medical centers to manage more patients efficiently.

Keywords: cardiac telerehabilitation, remote patient monitoring, telemedicine platform, cardiovascular disease, digital health, medical device, remote healthcare, post-surgery rehabilitation, chronic care management, HealthTech